Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02644967 |
Title | A Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination With Ipilimumab or Pembrolizumab in Patients With Metastatic Melanoma |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Idera Pharmaceuticals, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
The University of Arizona Cancer Center | Tucson | Arizona | 85719 | United States | Details | |
Moffitt Cancer Center Research Institute | Tampa | Florida | 33612 | United States | Details | |
University of Iowa Hospitals and Clinics | Iowa City | Iowa | 52242 | United States | Details | |
University of Kansas Cancer Center | Westwood | Kansas | 66205 | United States | Details | |
Roswell Park Cancer Institute | Buffalo | New York | 14263 | United States | Details | |
Icahn School Of Medicine at Mount Sinai | New York | New York | 10029 | United States | Details | |
Gabrail Cancer Center | Canton | Ohio | 44718 | United States | Details | |
Vanderbilt-Ingram Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
University of Utah- Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | United States | Details |